Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection (Q44218117)

30 November 2017

title

Beneficial effect of anti-interleukin-4 antibody when administered in a murine model of tuberculosis infection (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

3

1 reference

30 November 2017

Eleanor Roy

1

1 reference

30 November 2017

John Brennan

series ordinal

2

1 reference

30 November 2017

Douglas B Lowrie

series ordinal

4

1 reference

30 November 2017

publication date

21 December 2007

1 reference

30 November 2017

1 reference

30 November 2017

volume

88

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

197-202

1 reference

Current strategies in TB immunotherapy.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

IL-4 in tuberculosis: implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Type 2 Cytokine Gene Activation and Its Relationship to Extent of Disease in Patients with Tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Polarization of PPD-specific T-cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Th2 cytokines in susceptibility to tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

7 January 2021

IL-13 effector functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Agents against cytokine synthesis or receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

IgE in asthma and atopy: cellular and molecular connections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2007.11.005

10.1016/J.TUBE.2007.11.005

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference